Biomerica, Inc. (NASDAQ:BMRA) Short Interest Down 53.5% in January

Biomerica, Inc. (NASDAQ:BMRA) was the recipient of a significant drop in short interest in January. As of January 15th, there was short interest totalling 364,100 shares, a drop of 53.5% from the December 31st total of 782,800 shares. Based on an average trading volume of 894,000 shares, the days-to-cover ratio is presently 0.4 days.

Biomerica Price Performance

Shares of NASDAQ BMRA traded down $0.03 during midday trading on Wednesday, hitting $0.66. 367,183 shares of the company’s stock were exchanged, compared to its average volume of 23,560,881. The firm’s fifty day simple moving average is $0.37 and its 200-day simple moving average is $0.35. The company has a market cap of $12.03 million, a PE ratio of -1.93 and a beta of -1.04. Biomerica has a twelve month low of $0.24 and a twelve month high of $1.35.

Biomerica (NASDAQ:BMRA) last announced its quarterly earnings results on Tuesday, January 14th. The company reported ($0.06) EPS for the quarter. Biomerica had a negative return on equity of 90.19% and a negative net margin of 100.52%.

About Biomerica

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.